Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis
Boang Han, Yu Wang, Shen Yue, Yun-hao Zhang, Lun Kuang, Bin-bin Gao, Yue Wang, Ziyu Zhang, Xiaohong Pu, Xin-fa Wang, Chi-chung Hui, Ting-ting Yu, Chen Liu, Steven Y. Cheng
Boang Han, Yu Wang, Shen Yue, Yun-hao Zhang, Lun Kuang, Bin-bin Gao, Yue Wang, Ziyu Zhang, Xiaohong Pu, Xin-fa Wang, Chi-chung Hui, Ting-ting Yu, Chen Liu, Steven Y. Cheng
View: Text | PDF
Research Article Development Oncology

Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis

  • Text
  • PDF
Abstract

Suppressor of fused (SUFU) is widely regarded as a key negative regulator of the sonic hedgehog (SHH) morphogenic pathway and a known tumor suppressor of medulloblastoma (MB). However, we report here that SUFU expression was markedly increased in 75% of specimens compiled in a tissue array comprising 49 unstratified MBs. The SUFU and GLI1 expression levels in this MB array showed strong positive correlation, which was also identified in a large public data set containing 736 MBs. We further report that increasing Sufu gene dosage in mice caused preaxial polydactyly, which was associated with the expansion of the Gli3 domain in the anterior limb bud and heightened Shh signaling responses during embryonic development. Increasing Sufu gene dosage also led to accelerated cerebellar development and, when combined with ablation of the Shh receptor encoded by Patched1 (Ptch1), promoted MB tumorigenesis. These data reveal multifaceted roles of SUFU in promoting MB tumorigenesis by enhancing SHH signaling. This revelation clarifies potentially counterintuitive clinical observation of high SUFU expression in MBs and may pave way for novel strategies to reduce or reverse MB progression.

Authors

Boang Han, Yu Wang, Shen Yue, Yun-hao Zhang, Lun Kuang, Bin-bin Gao, Yue Wang, Ziyu Zhang, Xiaohong Pu, Xin-fa Wang, Chi-chung Hui, Ting-ting Yu, Chen Liu, Steven Y. Cheng

×

Figure 3

Preaxial polydactyly in 4nSD mice is associated with heightened Shh signaling.

Options: View larger image (or click on image) Download as PowerPoint
Preaxial polydactyly in 4nSD mice is associated with heightened Shh sign...
(A) RNA in situ hybridization analysis in E11.5 hind limb buds for Shh (n = 3), Gli1 (n = 6), Ptch1 (n = 6), Gli3 (n = 5), and Hand2 (n = 2). (B) Western analysis of protein expression in hind limbs of E11.5 mouse embryos. After dissection and cleaning, the limb buds were cut in the middle to separate anterior and posterior regions. The Sufu signal here encompasses both mouse and human proteins, as the antibody used reacts to both. Tissues from 4 limb buds were pooled for each sample analyzed. (C) Real-time qPCR analysis in MEFs freshly isolated from 4nSD or WT control embryos. The cells were treated with ShhN or control medium for 24 hours to activate signaling responses. The experiment was repeated 3 times (n = 3). Data represent mean ± SD, and 1-way ANOVA with Dunnett’s post hoc test was used for statistical analysis. (D) Western analysis in MEFs as described in C; the experiment was repeated 4 times (n = 4). (E) Western analysis of protein turnover and (F) quantification thereof in MEFs. CHX treatment was initiated 24 hours after signaling activation with conditioned mediums as above. The experiment was repeated 2 times (n = 2), and data represent mean ± SD. 2-way ANOVA with Bonferroni’s post hoc test was used for statistical analysis. *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts